NYP Advances vs AmyloidConnect

NYP Advances brings together the latest updates in heart failure with expert reviews of clinical trials that have shaped the field, our state-of-the-art heart failure conference series, as well as insight into ongoing heart failure research at NYP, all available at your fingertips. Stay up-to-date on breakthroughs in the treatment of heart failure through the innovative work being led by the teams at NewYork-Presbyterian, with world-class doctors from Columbia and Weill Cornell Medicine. NewYork-Presbyterian is a top hospital per U.S. News & World Report (2024-2025).

AmyloidConnect helps amyloidosis patients find their path to better treatment — matching you to clinical trials using AI, and helping you get there. WHY AMYLOIDCONNECT? Amyloidosis is a rare disease where abnormal proteins build up in organs, often diagnosed 2-3 years after symptoms begin. AmyloidConnect closes that gap — helping patients get matched to the right clinical trials, understand their diagnosis, and find specialists who truly understand this disease. WHAT YOU GET, FREE: AI Trial Matching — matched to clinical trials based on your amyloid type, organ involvement, treatment history, and location Care Copilot — ask questions about your condition, understand your trial options, and get lab results interpreted in plain English Disease Education — comprehensive resources on AL, ATTR, and AA amyloidosis Specialist Finder — locate amyloidosis centers of excellence and specialists near you, including Mayo Clinic, Boston Medical Center, Stanford, and University of Chicago Medicine Travel Coordination — book flights, hotels, and transportation to your trial site HIPAA COMPLIANT Your health data is protected with enterprise-grade security. We never sell your information, and you control what you share. AmyloidConnect is free for patients. Always. This app is intended for educational purposes and does not replace professional medical advice. Always consult your physician regarding your diagnosis and treatment.